319 related articles for article (PubMed ID: 32438456)
1. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
[TBL] [Abstract][Full Text] [Related]
2. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
3. LPA
Valdés-Rives SA; Arcos-Montoya D; de la Fuente-Granada M; Zamora-Sánchez CJ; Arias-Romero LE; Villamar-Cruz O; Camacho-Arroyo I; Pérez-Tapia SM; González-Arenas A
Cells; 2021 Apr; 10(4):. PubMed ID: 33916643
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion.
Hoelzinger DB; Nakada M; Demuth T; Rosensteel T; Reavie LB; Berens ME
J Neurooncol; 2008 Feb; 86(3):297-309. PubMed ID: 17928955
[TBL] [Abstract][Full Text] [Related]
6. LPA
Valdés-Rives SA; de la Fuente-Granada M; Velasco-Velázquez MA; González-Flores O; González-Arenas A
Int J Biochem Cell Biol; 2019 May; 110():91-102. PubMed ID: 30849522
[TBL] [Abstract][Full Text] [Related]
7. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
9. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
[TBL] [Abstract][Full Text] [Related]
10. Identifying lysophosphatidic acid receptor subtype 1 (LPA
Kwon JH; Gaire BP; Park SJ; Shin DY; Choi JW
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1237-1245. PubMed ID: 30071304
[TBL] [Abstract][Full Text] [Related]
11. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
[TBL] [Abstract][Full Text] [Related]
12. LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.
Loskutov YV; Griffin CL; Marinak KM; Bobko A; Margaryan NV; Geldenhuys WJ; Sarkaria JN; Pugacheva EN
Oncogene; 2018 Mar; 37(11):1457-1471. PubMed ID: 29321663
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY
Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517
[TBL] [Abstract][Full Text] [Related]
14. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
[TBL] [Abstract][Full Text] [Related]
16. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
17. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid receptor 1 (LPA
Gaire BP; Sapkota A; Song MR; Choi JW
J Neuroinflammation; 2019 Aug; 16(1):170. PubMed ID: 31429777
[TBL] [Abstract][Full Text] [Related]
19. Complexities of lysophospholipid signalling in glioblastoma.
Ng W; Pébay A; Drummond K; Burgess A; Kaye AH; Morokoff A
J Clin Neurosci; 2014 Jun; 21(6):893-8. PubMed ID: 24746442
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.
Miyabe C; Miyabe Y; Nagai J; Miura NN; Ohno N; Chun J; Tsuboi R; Ueda H; Miyasaka M; Miyasaka N; Nanki T
Arthritis Res Ther; 2019 Aug; 21(1):191. PubMed ID: 31429784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
